Roger Connor

We will have to start preparing other markets at the right time, depending on when we believe the U.S. is going to peak and what level of penetration of the 115 million will be achieved, this will all determine when the next launches can be supported, including China.

The key project is the expansion of antigen bulk production which will come online in 2024. That will be what will create the next step change in our capacity.